Curriculum vitaelisbonclinicalnephrologyupdate.com/images/speakers/Biff-Franklin... · 1 Curriculum...

1

Curriculum vitae Date Prepared:

5/20/2016

Name: Biff Franklin Palmer, M.D., FACP, FASN

Office Address:

5323 Harry Hines Blvd. Dallas, TX 75390-8856

Work Phone: 214-648-7848 Work E-Mail: [email protected]

Work Fax: 214-648-2071 Place of Birth: Munich, Germany Education Year Degree

(Honors) Field of Study

Institution

1977 B.S., Magna Cum Laude

Biology Baylor University, Waco, TX

1981 M.D. UT Southwestern Medical School Postdoctoral Training Year(s) Titles Specialty/Discipline

Institution

1981-82 Internal Medicine

Internship Walter Reed Army Medical Center, Washington, DC

1982-84 Internal Medicine

Residency Walter Reed Army Medical Center, Washington, DC

1985-88 Research Fellow

Dept of Nephrology Walter Reed Army Institute of Research, Washington, DC

1988-89 Clinical Fellowship

Nephrology Division UT Southwestern Medical Center, Parkland Memorial Hospital, Dallas VAMC, Dallas, TX

Current Licensure and Certification Licensure: Virginia and Texas (Both Current) Board and Other Certification: Flex Exam, June 1981 American Board Exam in Internal Medicine, September 1984 American Board Exam in Nephrology, 1990 American Board Exam Recertified in Nephrology, 2008

2

Honors and Awards Year Name of Honor/Award Awarding Organization

1979, 1980 Texas Merit Scholarship

UTSW Medical School (Awarded to top 10 medical students annually)

1980 Alpha Omega Alpha Honor Medical Society (Awarded in Junior Student)

UTSW Medical School

1985 Army Commendation Medal

US Army

1993-94 Outstanding Teacher Award (Faculty members can receive this award only one time)

Parkland Memorial Hospital Internal Medicine Housestaff

2005 Best Doctors in Dallas D Magazine, October 2005 Issue 2005-06 Outstanding Teacher Awarded by Class of 2008 2005-06 Core Clerkship

Teaching Award in Internal Medicine

Awarded by Class of 2007

2007 Distinguished Alumni Award

Beta Tau Chapter of Alpha Epsilon Delta, Baylor University, Waco, TX

2007 Socrates Award Awarded by UTSW Medical School Class of 2007 and 2008 2007-Present Mentor in Seldin

College Chosen as a Mentor for Seldin College based on Teaching Excellence

2008 Outstanding Teacher Awarded by Class of 2011 2010 Outstanding Teacher Awarded by Class of 2013 2010 Best Doctors in Dallas D Magazine, October 2010 Issue 2011 Outstanding Teacher Awarded by Class of 2014 2012 Outstanding Teacher Awarded by Class of 2015 2012 Regents Outstanding

Teacher Award University of Texas

2012 Best Doctors in Dallas D Magazine, October 2012 Issue 2013 Outstanding Teacher Awarded by Class of 2016 2013 Fellow Southwestern

Academy of Teachers (SWAT)

Elected by University of Texas Southwestern Medical Center

2013 Appointed to prestige title of “Distinguished Teaching Professor”

University of Texas Southwestern Medical Center

2014 Outstanding teacher Awarded by Class of 2016

3

2014 Outstanding teacher Awarded by Class of 2017 2014 Outstanding Teaching

Award in Nephrology Voted by Fellows in Nephrology Training Program

2015 Outstanding Teacher Awarded by Class of 2017 2015 Outstanding Teacher Awarded by Class of 2018 2016 Elected to Kenneth I.

Shine Academy of Health Science Education

The University of Texas

Faculty Academic Appointments Year(s) Academic Title Department Academic Institution 1984-85 Staff Internist &

Director of Continuing Medical Education

Internal Medicine 121 Evacuation Hospital, US Army Seoul, Korea

1986-88 Assistant Professor Internal Medicine Uniformed Services of the Health Sciences, Bethseda, MD

1989-94 Assistant Professor Internal Medicine UTSW Medical Center, Dallas, TX 1994-98 Associate Professor Internal Medicine UTSW Medical Center, Dallas, TX 1999-Present Professor (with

tenure) Internal Medicine UTSW Medical Center, Dallas, TX

Appointments at Hospitals/Affiliated Institutions Past Year(s) Position Title Department/Division Institution 1989-94 Associate Medical

Director Renal Transplantation UTSW Medical Center,

Dallas, TX 1994-97 Medical Director Chronic Dialysis Unit and

Peritoneal Dialysis Program Parkland Memorial Hospital

1996-2001 Medical Director Acute Dialysis Unit Parkland Memorial Hospital 1997-2001 Director Clinical Nephrology UTSW Medical Center,

Dallas, TX 1998-99 Acting Chief Nephrology division UTSW Medical Center,

Dallas, TX 2002-2011 Program Director Nephrology Fellowship

Program UTSW Medical Center, Dallas, TX

2004-2011 Associate Training Program Director

Internal Medicine UTSW Medical Center, Dallas, TX

4

Other Professional Positions Year(s) Position Title Institution 1981-1988 Major US Army (Honorable Discharge) US Army Major Administrative/Leadership Positions Year(s) Position Title Institution 1997-2001 Director Clinical Nephrology UTSW Medical Center, Dallas, TX 1998-99 Acting Chief Nephrology division UTSW Medical Center, Dallas, TX 2002-2011 Program Director Nephrology Fellowship

Program UTSW Medical Center, Dallas, TX

2004-2011 Associate Training Program Director Internal Medicine

UTSW Medical Center, Dallas, TX

Committee Service Year(s) Name of Committee Institution/Organization UTSW 1991-2008 Moderator, Nephrology Section: Updates in

Internal Medicine UTSW Medical Center

2000-2008 Course Director: Updates in Internal Medicine UTSW Medical Center 2005-2011 Committee to Review Clinical Competence

(CRCC) UTSW Medical Center

2005-2011 Curriculum Committee UTSW Medical Center 2012-Present MSIV Advisory Committee UTSW Medical Center 2014-Present Section leader: Curriculum reform Renal GU UTSW Medical Center Hospital 1999-2001 Member Medical Executive Committee Zale

Lipshy University Hospital

National/International 1992 Abstract reviewer- American Society of

Nephrology: Clinical Nephrology and Dialysis American Society Nephrology

1997 Abstract reviewer- American Society of Nephrology: Chronic Renal Failure

American Society Nephrology

1999 Abstract reviewer- American Society of American Society Nephrology

5

Nephrology: Chronic Renal Failure 1999 Abstract review category Chair- American

Society of Nephrology: Treatment Comparisons: Epidemiology/Health Services Research


2001-2002 Program Committee Member, Joint American Society Nephrology and International Society Nephrology, World Congress, San Francisco


2002-2003 Program Committee Member, National Kidney Foundation Spring Meeting, Dallas Texas

National Kidney Foundation

2005-2008 Member American Society of Nephrology Education Committee


2006 Abstract reviewer- American Society of Nephrology: Chronic Kidney Disease


2008 Abstract reviewer- American Society of Nephrology: Metabolic Bone Disease


2008-2011 Member American Society of Nephrology Committee on Corporate Relations


2009-Present Subspecialty Board of Nephrology ABIM American Board of Internal Medicine

2011 Abstract reviewer- American Society of Nephrology: Fluid and Electrolytes


2012 Abstract reviewer- American Society of Nephrology: Fluid and Electrolytes


Professional Societies Dates Society Name, member 1988-1994 American College of Physicians, Member 1990-1991 American Medical Association, Member 1988-Present Texas Medical Association, Member 1984-Present 38th Parallel Medical Society, Member 1988-Present Dallas County Medical Society, Member 1988-Present International Society of Nephrology, Member 1988-2008 American Society of Nephrology, Member 1990-Present Southern Society for Clinical Investigation, Member Dates Fellowships 1990-Present Fellow American College of Physicians

6

2008-Present Fellow American Society of Nephrology Editorial Activities Year(s) Journal Name Editor/Associate Editor 1997-Present Editor: Southwestern Internal Medicine Conference, The American Journal of the

Medical Sciences 2006-09 Co-Editor: Renal and Urology Section: PocketMedicine/Internal Medicine for the Palm

Pilot 2010-Present Associate Editor: American Journal of Nephrology Editorial Board 2005-09 Nephrology Self-Assessment Program (NephSAP) 2006-2010 Clinical Journal of the American Society of Nephrology 2008 - 2012 Medical Knowledge Self-Assessment Program (MKSAP 15) Nephrology 2009-Present Clinical Nephrology 2014-Present Editorial Board American Journal of Kidney Disease (Member Acid-Base and

Electrolyte Advisory Board) Ad Hoc Reviewer Journal of Diabetes and its Complications

New England Journal of Medicine Kidney International Journal of the American Society of Nephrology Clinical Journal of the American Society of Nephrology American Journal of Kidney Disease Nephrology, Dialysis, and Transplantation Journal of Urology Annals of Pharmacotherapy Critical Care Epilepsia Pediatric Nephrology American Journal of Physiology

7

Teaching Activities Year(s) Activity Medical and graduate school didactic and small group teaching Approximately 2006-Present

MSI Regulation of ECF Volume, Clinical Correlation on Congestive Heart Failure (3 Formal Hours of lecture)

Approximately 2000-2006

MSI Renal Physiology Course: Calcium, Phosphate, and Magnesium homeostasis, Regulation of ECF Volume, Clinical Correlation on Congestive Heart Failure (6 Formal Hours)

Approximately 2000-2006

MSII Clinical Correlation for Pharmacology: Treatment of Hypertension (1 Formal Hour)

Approximately 2000-Present

MSII Entire Renal Block on Diseases of the Kidney (10-11 Formal hours of lecture)

Approximately 1995-Present

MSIII Fluid and Electrolyte Cases to each block of students rotating on Internal Medicine (5-6 Sessions each lasting 2 hours per year)

Medical student rotations 1989- Present Attend Yearly on Internal Medicine either once or twice 1989-Present Attend 1-2 times on Renal Consult Service 1989-Present Attend 1-2 times on Acute Dialysis Service 1989-Present Attend 1-2 times on Renal Transplant Service Postgraduate medical education (graduate & continuing medical education) 1989- present Lecture Every year on Various Renal topics for Core and Ambulatory Lecture Series for

Internal Medicine Housestaff Approximately 1995-present

Annual Nephrology Board review for Housestaff

1990- Present Frequent Attending for Housestaff Resident Report 1989- present Lecture Every year on Various Renal topics for Nephrology Fellows Invited Lectures Year(s) Title Location International 1999 Moderator and Invited Lecturer, Clinical

Case Discussions International Society of Nephrology, Buenos Aires, Argentina

2005 Invited lecturer, Highlights of Clinical Nephrology From the ASN 2004 National Meeting

European Dialysis Transplant Association Meeting, Istanbul Turkey

8

2005 Invited lecturer, Cerebral Salt Wasting, Hyperkalemia with RAAS blockers

1st International Course on Fluid, Electrolyte, and Acid-Base disorders In clinical practice, Parma Italy


International Society of Nephrology, Rio de Janeiro, Brazil


European Dialysis Transplant Association Meeting, Barcelona, Spain

2007 Invited lecturer, 1. Disorders of Potassium, 2. Complications Associated with use of RAAS Blockers, 3. Cerebral Salt Wasting, 4. Hyperkalemia with RAAS blockers

2nd International Course on Fluid, Electrolyte, and Acid-Base disorders In clinical practice, Parma Italy

2007 Invited Lecturer, Proteinuria: the cardio-renal link

10th Intl CME Mediciti Hospitals, Hyderabad, India

2008 Invited Lecturer, Renal Complications Associated with Treatment of Hypertension

Brazilian Society of Nephrology, Curitiba Brazil

2009 Invited Lecturer, Renal Complications Associated with Treatment of Hypertension

Mexican Society of Nephrology, Mexico City, Mexico

2012 Role of Vasopressin antagonists in patients with CHF

55th Japanese Society of Nephrology Yokohama, Japan

2012 Invited lecturer: Intl Course of fluid and electrolytes and acid-base disorders: Hypokalemia, Hyperkalemia, and Hyponatremia

Asuncion, Paraguay

2012 Invited lecturer: Renal dysfunction Complicating the treatment of hypertension

8th Uruguayan Congress of Nephrology, Montivideo, Uruguay

2012 Invited lecturer: Potassium transport in the kidney: clinical implications

Moroccan Society of Nephrology, Casablanca, Morocco

2012 Invited Lecturer: Potassium transport in the kidney: clinical implications

University of Lyon Medical School, Lyon France

2013 Invited Lecturer: Weight loss at Altitude, the role of hypoxia inducible factor

Swiss Winter Conference on Ingestive behavior, St. Moritz

2013 Invited Lecturer: (3 talks) Sexual dysfunction in CKD, Hyperkalemia, Electrolyte cases

5th South Brazilian Congress of Nephrology, Gramado Brazil

2013 Invited Lecturer: Novel Therapy for Hyponatremia

30th National Congress of Turkish Society of Nephrology, Antalya Turkey

March 2014 Invited Lecturer: Challenging electrolyte cases 1st International Renal Conference Brugge, Belgium

May 2014 Invited lecturer: Renal dysfunction 3rd Nephrology Symposia “Fronteras

9

complicating the treatment of hypertension 2014” Santiago, Chili August 2014 Invited lecturer: RAAS Inhibitor Debate: Should

they be stopped in CKD? European Society of Cardiology Congress, Barcelona, Spain

March 2015 Invited Lecturer: Sodium and water physiology ISN World Congress of Nephrology CapeTown, South Africa

March 2015 Invited Lecturer: Hyperkalemia: Epidemiology, Pathophysiology,and clinical consequences

ISN World Congress of Nephrology CapeTown, South Africa

April 2015 Invited lecture: Hyponatremia 3rd Intl Renal Meeting Sardinia June 2015 3 Invited lectures:Diagnosis and Mgt.

Hyponatremia, Hyperkalemia, Electrolyte cases Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil

September 2015

Approach to hyponatremia, Approach to hypokalemia

Khyber medical institute, Srinigar, India (Kashmir)

November 2015

4 lectures: Approach to hyponatremia, Approach to hyperkalemia, Acid base cases, Vaptan therapy

32nd Chilean Congress Nephrology and Hypertension Santiago Chile

March 2016 Diagnosis, treatment of hyponatremia, Diagnosis treatment of hyperkalemia

Mayo Clinic NefroUSP Symposium, Sao Paulo Brazil

May 2016 Approach to hyponatremia, AVP receptor antagonists in treatment of hyponatremia

Mayo Clinic Nephrology meeting, Buenos Aires, Argentina

National 1996 Disorders of Calcium, Phosphate, and

Magnesium in Patients with Advanced Liver Disease

American Society Of Nephrology National meeting (New Orleans)

2002-2009 Invited Lecturer, Potassium Homeostasis: Hyperkalemic and Hypokalemic disorders

American Society of Nephrology Board Review Course, San Francisco, CA

2002-2009 Invited Lecturer, Electrolyte Case Discussion


2007-2009 Invited Lecturer, Respiratory Acid-Base Disorders


2004 Invited Lecturer, Diabetic Nephropathy American Diabetes Association Annual Advanced Postgraduate Course, San Francisco, CA

2004 Invited Lecturer, Metabolic Complications of Diuretic Therapy

National Kidney Foundation Spring Meeting, Chicago Ill

10

2004 Invited lecturer, Male and Female Sexual Dysfunction in Chronic Kidney Disease

American Society of Nephrology National Meeting, St. Louis

2005 Invited lecturer, Pathophysiology, Prevalence, and Factors Responsible for Sexual Dysfunction in Dialysis Patients

25th Annual Conference on Peritoneal Dialysis, Tampa Florida

2005 Invited lecturer, Highlights of Clinical Nephrology From the ASN National Meeting

American Society of Nephrology Regional Meetings: Washington D.C., Chicago, Seattle,

2005 Invited Lecturer, Angiotensin II and mechanisms in Cardio-renal disease

National Kidney Foundation Spring Meeting, Washington DC

2005 Invited lecturer, Literature review: Fluid and electrolytes literature review

American Society of Nephrology National Meeting, Philadelphia

2006 Invited lecturer, Highlights of Clinical Nephrology from ASN National Meeting

American Society of Nephrology Regional Meetings, Washington D.C., New York, Toronto

2006 Invited Lecturer, Recertification Course

American Society of Nephrology National Meeting, San Diego

2007 Invited lecturer, Highlights of Clinical Nephrology from ASN National Meeting

American Society of Nephrology Regional Meetings, Washington D.C

2007 Co-Chairman and Invited Lecturer, Recertification Course

American Society of Nephrology National Meeting, San Francisco

2007 Invited Lecturer, Vasopressin antagonists, better, more expensive, or both? A skeptic”s view

American Society of Nephrology National Meeting, San Francisco

2008 Co-Chairman and Invited Lecturer, Recertification Course


2008 Invited Lecturer, Nephrology Quiz and Questionnaire Session Fluid and Electrolytes


2008 Moderator: Revisiting the Cardio-Renal Syndrome Breakfast Symposia


2009 Invited Lecturer, Renal Safety: Need for Novel Biomarkers

American College of Clinical Pharmacology Annual Meeting, San Antonio

2009 Invited Lecturer, Nephrology Quiz and Questionnaire Session, Fluid and electrolytes


11

2009 Invited Lecturer: Indications for Use of Vasopressin Receptor Antagonists


2009 Chairman and Invited Lecturer, Recertification Course



American Society of Nephrology National Meeting, Denver

2010 Invited Lecturer, Forefronts in Hyponatremia Lunch Symposia

American Society of Nephrology National Meeting, Denver



2011 Invited Lecturer, Potassium Transport in the Kidney and Clinical Consequences


2011 Invited Lecturer, Dyskalemias in Older Adults: Evaluation and Management


2011 Invited Lecturer, Overview of Renal Acid Handling


2011 Invited Lecturer, Pathophysiology of Hyperkalemia


2011 Invited Lecturer, Diagnosis and Management of Hyperkalemia


2011 Invited Lecturer, Case Studies of Hyperkalemia American Society of Nephrology National Meeting, Philadelphia



2012 Disorders of potassium: hyperkalemia American Society of Nephrology National Meeting, San Diego

2012 Disorders of potassium: Illustrative cases of hyperkalemia


2012 Evidence based Management of acute severe hyperkalemia


2012 Hyponatremia in the patient with Congestive Heart Failure


2013 Disorders of potassium:Hypokalemia American Society of Nephrology National Meeting, Atlanta

2013 Disorders of potassium: Illustrative cases of hypokalemia

American Society of Nephrology National Meeting, Atlanta

2013 Clinical use of V2 receptor antagonists American Society of Nephrology National Meeting, Atlanta

2013 Invited Lecturer, Nephrology Quiz and American Society of Nephrology

12

Questionnaire Session, Fluid and electrolytes National Meeting, Atlanta 2013 Management of hyponatremia American Society of Nephrology

National Meeting, Atlanta 2014 Cardiorenal and Hepatorenal syndromes Nephrology-2014 Harvard

Medical School, Boston Mass 2014 Invited lecturer 2 talks: Acute Kidney Injury,

Electrolyte case workshop UC San Francisco 18th Annual Management of Hospitalized Patient

2014 Treatment with crystalloids Solutions: Benefits and adverse effects


2014 Diagnosis and management of hyperkalemia American Society of Nephrology National Meeting, Philadelphia

2015 Nephrotic syndrome American College of Rheumatology Winter Symposia, Snowmass Colorado

2015 Disorders of serum sodium

National Kidney Foundation Spring Meeting, Dallas Texas

2015 Chronic hyponatremia: the role of Vasopressin antagonists

National Kidney Foundation Spring Meeting, Dallas Texas

2015 Overview of the approach to hyponatremia National Kidney Foundation Spring Meeting, Dallas Texas

2015 Acid-base case workshop National Kidney Foundation Spring Meeting, Dallas Texas

2015 Resuscitation fluids: what is the appropriate fluid to use?

American Society of Nephrology Meeting, San Diego

2015 Clinical Hyperkalemia: Consequences and Treatment Strategies

American Society of Nephrology Meeting, San Diego

2016 Regulation of Potassium Homeostasis and Renal Disease

Experimental Biology Meeting, San Diego

2016 Hypokalemia and Hyperkalemia American Society of Nephrology Board Review Course, Chicago

2016 Anion gap acidosis American Society of Nephrology Board Review Course, San Francisco, CA

2016 Selection of fluid therapy in patients with medical or surgical conditions

American Society of Nephrology Meeting, Chicago

2016 Are diuretics harmful to kidney function American Society of Nephrology Meeting, Chicago

13

Bibliography Peer-Reviewed Publications

Original Research Articles

1. Aronson NE, Palmer BF. Acute viral hepatitis in American soldiers assigned to Korea.

Southern Med J. 81:949-951, 1988. 2. Palmer BF, Henrich WL. Treatment of autonomic insufficiency. Drug Therapy. 19:29-

38, 1989. 3. Palmer BF, Hernandez J, Sagalowsky A, Dawidson I, Helderman JH. Documentation

of fungal pyelonephritis of the renal allograft by fine needle aspiration cytology. Trans Proc. 21:3598-3599, 1989.

4. Palmer BF, Hernandez J, Sagalowsky A, Dawidson I, Helderman JH. Diagnosis of acute bacterial pyelonephritis of the renal allograft by fine needle aspiration cytology. Transplantation. 48:152-154, 1989.

5. Palmer BF, Eigenbrodt E, Henrich WL. Cranial nerve deficit: A clue to the diagnosis of ethylene glycol poisoning. Am J Med. 87:91-92, 1989.

6. Dawidson I, Rooth P, Alway C, Dulzo T, Palmer B, Lu C, Peters P, Sagalowsky A, Zsolt S. Verapamil prevents post-transplant delayed function and cyclosporine A nephrotoxicity. Trans Proc. 22:1379-1380, 1990.

7. Dawidson IJ, Coorpender L, Fisher D, Helderman JH, Hull A, Palmer B, Peters P, Sagalowsky A, Sandor ZF, Toto R, Reisch J. Impact of race on renal transplant outcome. Transplantation. 49:63-67, 1990.

8. Palmer BF, Toto RD. Cyclosporine-A induced severe neurologic toxicity in three renal transplant patients. Am J Kidney Ds 18:116-121, 1991.

9. Palmer BF, Dawidson I, Sagalowsky A, Sandor Z, Lu CY. Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation. 52:640-645, 1991.

10. Dawidson I, Lu C, Diller K, Palmer B, Peters P, Risser R, Rooth P, Sagalowsky A, Sandor Z, Seney F. Verapamil improves the outcome after cadaver renal transplantation. J Am Soc Nephrol. 2:983-990, 1991.

11. Dawidson I, Sandor Z, Coorpender L, Palmer B, Peters P, Lu CY, Sagalowsky A, Risser R, Williams C. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation. 53:774-782, 1992.

12. Palmer BF. The effect of dialysate composition on cardiovascular hemo-dynamics. Seminars in Dialysis. 5:54-60, 1992.

13. Tank JE, Palmer BF. Simultaneous "In Series" hemodialysis and hemoperfusion in the management of valproic acid overdose. Am J Kidney Ds. 22:341-344, 1993.

14. Barton KL, Palmer BF. Bilateral infarction of the vastus lateralis muscle in a diabetic patient: Case report and review of the literature. Diabetes Complications. 7:221-223, 1993.

15. Palmer BF. Nephrotic edema: Pathgenesis and treatment. Am J Med Sci. 306:53-67,1993.

16. Ahsan N, Palmer BF, Wheeler DD, Greenlee R, Toto RD. Intravenous immunoglobulin induced osmotic nephrosis. Arch Int Med. 152:1985-1987, 1994.

17. Ahsan N, Wheeler DE, Palmer BF. Leprosy associated renal disease: case report and review of the literature. J Am Soc Nephrol. 5:1546-1552,1995.

14

18. Palmer BF, Sagalowsky A, McQuitty D, Dawidson I, Vazquez M, Lu C. Lymphoproliferative disease presenting as obstructive uropathy in a renal transplant patient. J Urology. 153:392-394, 1995.

19. Palmer BF. Microalbuminuria: Treatment and Implications. The Kidney. 1: 1-4, 1995 20. Palmer BF, Henrich WL. Clinical acute renal failure secondary to non-steroidal

antiinflammatory drugs. Seminars in Nephrology. 15: 214-227, 1995. 21. Palmer BF, Henrich WL. Systemic complications of non-steroidal antiinflammatory

drug use. Advances Internal Medicine. 41: 605-639, 1996. 22. Palmer BF. Renal complications associated with use of non-steroidal antiinflammatory

agents. J Invest Med. 43: 516-533, 1995. 23. Palmer BF. An over-the-counter catastrophe. The Cortlandt Forum. 9: 157-158, 1996. 24. Palmer BF. Cholesterol and the kidney: A crystal clear complication. The Cortlandt

Forum. 9: 166-167, 1996. 25. Palmer BF. Hypomagnesemia in the chronic alcoholic patient. The Cortlandt Forum.

9:156-163, 1996. 26. Palmer BF, Alpern RJ. The pathogenesis of edema formation in the nephrotic

syndrome. Kidney Intl. 51 (Suppl. 59),S21-S27, 1997. 27. Palmer BF. The renal tubule in the progression of chronic renal failure: J Invest Med.

45: 346-361, 1997. 28. Palmer BF, Alpern RJ. Metabolic Alkalosis. J Am Soc Nephrol. 8:1462-1469, 1997. 29. Palmer BF, Alpern RJ. Liddle's Syndrome. Am J Med. 104:301-309, 1998. 30. Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol. 10:1381-1388, 1999. 31. Palmer BF. Pathogenesis of ascites and renal salt retention in cirrhosis. J Invest Med.

47:183-202, 1999. 32. Palmer BF. Management of sexual dysfunction: Responsibility of the primary care

physician or the specialist ? An Editorial. NKF Website. Adv Renal Replacement Therapy. 6 #4, 1999.

33. Palmer BF. Hyponatremia in a neurosurgical patient: SIADH vs Cerebral salt wasting. Nephrology Dialysis Transplantation. 15: 262-268, 2000.

34. Islam KN, O,Byrne D, Devaraj S, Palmer B, Grundy S, Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis. 150:217-224, 2000.

35. Palmer BF. The Effectiveness of Hemodialysis in the Extracorporeal Therapy of Phenobarbital Overdose. Am J Kidney Ds. 36:640-643, 2000.

36. Palmer BF. Hyponatraemia with natriuresis in neurosurgical patients: Letter and Reply. Nephrol. Dial. Transplant. 15: 1707-1708, 2000.

37. Palmer BF. Individualizing the Dialysate in the Hemodialysis Patient. Semin Dial. 14: 41-49, 2001.

38. Palmer BF. Letter and Reply #2, Hyponatremia in a neurosurgical patient. Nephrology Dialysis Transplantation. 16:865-867, 2001.

39. Palmer BF. Impaired Renal Autoregulation: Implications for the Genesis of Hypertension and Hypertension-Induced Renal Injury. American Journal of the Medical Sciences. 321:388-400, 2001

40. Palmer BF. Metabolic Alkalosis, Metabolic Acidosis, Hypokalemia, Hyperkalemia, Edema and Fluid Depletion. PocketMedicine/Internal Medicine for the Palm Pilot. B Scharschmidt, (ed.) 2002.

41. Palmer, BF, Hise MK. Medical Management of Early Renal Insufficiency. WebMD, Scientific American Medicine. Section 10: 1-9, 2002

15

42. Palmer BF. Metabolic disturbances in chronic renal failure. Saudi Journal of Kidney Diseases and Transplantation 13:273-280, 2002.

43. Palmer BF. Renal dysfunction complicating treatment of hypertension. N Engl J Med. 347:1256-1261, 2002.

44. Palmer BF. Sexual dysfunction in men and women with chronic kidney disease and end-stage renal disease. Adv Renal Replacement Therapy. 10:48-60, 2003.

45. Drazner MH, Palmer BF. Hypertonic saline: a novel therapy for advanced heart failure (editorial). Am Heart J. 145:377-9, 2003

46. Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH or CSW. Trends Endocrinol Metab 14:182-7, 2003

47. Palmer BF, Alpern RJ. Treating dyslipidemia to slow the progression of chronic renal failure (editorial) Am J Med 114:411-2, 2003

48. Palmer BF. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers: What to do if the serum creatinine and/or potassium concentration rises. Nephrol Dial Trans 18:1973-1975, 2003

49. Palmer BF, Gates JR, Lader M. Causes and management of Hyponatremia. Ann Pharmacother 37:1694-1702, 2003.

50. Palmer BF. Approach to the patient with renal disease. WebMD, Scientific American Medicine. Section 10 Part III: 1-8, 2004

51. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 351:585-592, 2004

52 Palmer BF, Hise MK. Management of chronic kidney disease. WebMD, Scientific American Medicine, Section 10 Part IV:1-11, 2004

53. Palmer BF. Outcomes associated with hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Disease 11:342-347, 2004

54. Palmer BF. The role of angiotensin receptor blockers in patients with chronic kidney disease. Medscape Primary Care 6(2), (E Publication),2004

55. Palmer BF. Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system. Letter and Reply. N Engl J Med 351:2450-2451,2004.

56. Palmer BF. Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease. Am J Medical Sci 328:330-343, 2004

57. Sterns R. Palmer BF. Fluid, Electrolyte and Acid-base disturbances. NephSAP. 5:10-62, 2006

58. Palmer BF. Approach to the patient with renal disease. ACP Medicine. Section III, 10-1-10-8, 2006

59. Palmer BF. Metabolic Alkalosis, Metabolic Acidosis, Hypokalemia, Hyperkalemia, Edema and Fluid Depletion. Pocket Medicine/Internal Medicine for the Palm Pilot. B Scharschmidt, (2ed.) 2006.

60. Palmer BF (Guest editor). Drugs with favorable effects in late stages of cardiovascular disease may have favorable effects for uncomplicated hypertension: new data on cardiovascular risk reduction. CME Report 2005 AHA Scientific Sessions, 2006

61. Barri Y, Palmer BF, Ram CV. Microalbuminuria, insulin resistance, diabetes, and kidney function: the latest concepts in pathology and pharmacologic treatment. Post Graduate Medicine Special Report 34-45, 2006

62. Naderi A, Palmer BF. Rhabdomyolysis and acute renal failure associated with influenza virus type B infection. Am J Med Sci 332:88-89, 2006

63. Palmer BF, Hise MK. Management of chronic kidney disease. WebMD, Scientific American Medicine, 2006

16

64. Naderi A, Palmer BF. Successful treatment of a rare case of boric acid overdose with hemodialysis. Am J Kidney Ds 48:e95-7, 2006

65. Palmer BF. Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol 27:287-293, 2007

66. Epstein BJ, Vogel K, Palmer BF. Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs 67: 1309-1327, 2007

67. Sterns R. Palmer BF. Fluid, Electrolyte and Acid-base disturbances. NephSAP. 6:210-280, 2007

68. Naderi A, Palmer BF. An unusual case of acute hyperkalemia during pregnancy. Am J Obstet Gynecol 197(3):e7-8, 2007

69. Palmer BF, Naderi A. Metabolic complications associated with use of thiazide diuretics. J Am Soc Htn 1:381-392, 2007

70. Palmer BF. Supratherapeutic Doses of Angiotensin Receptor Blockers to Decrease Proteinuria in Patients With Chronic Kidney Disease. Am J Nephrol 28:381-390, 2008

71. Toto R, Palmer BF. Rationale for Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor Treatment and End-organ Protection in Patients with Chronic Kidney Disease. Am J Nephrol 28:372-380, 2008

72. Palmer BF, Henrich WL. Recent Advances in the Prevention and Management of Intradialytic Hypotension. J Am Soc Nephrol 19:8-11, 2008

73. Naderi A, Farsian F, Palmer BF. Diabetic Muscle Necrosis. J Diabetes Complications 22: 150-152, 2008

74. Palmer BF. Improving blood pressure control with combined renin-angiotensin system blockade and thiazide diuretics in hypertensive patients with diabetes or kidney disease. Am J Cardio Vasc Drugs 8: 9-14, 2008

75. Palmer BF. Approach to fluid and electrolyte disorders and acid-base problems. Primary Care: Clinics in office practice. 35:195-213, 2008

76. Palmer BF. Management of changes in the serum creatinine and /or serum potassium concentration in the setting of renin-angiotensin system blockade. Medscape (E Publication), 2008

77. Palmer BF. Management of Hypertension in Patients With Chronic Kidney Disease and Diabetes Mellitus. Am J Med 121:(Suppl) S16-22, 2008

78. Palmer BF. Extracellular fluid volume in the hypoalbuminemic diabetic patient. Heart Fail Clin. 4(4):439-448, 2008

79. Palmer BF. Hypertension management in patients with renal insufficiency. Curr Hypertension Reports 10(5):367-73, 2008

80. Palmer BF. Hypertension and chronic kidney disease. US Nephrology 27-29, 2008 81. Palmer BF, Sterns R. Fluid, Electrolyte and Acid-base disturbances. NephSAP, 8:70—

165, 2009 82. Palmer BF. Hyponatremia in the intensive care unit. Semin Nephrol 29: 257-270, 2009 83. Stokes JB, Haupt A, Molitoris B, Kokemueller P, Ibrahim T and for the ASN Committee

on Corporate Relations and the ASN Council. ASN Policy on Managing Conflicts of Interest. J Am Soc Nephrol 20:1853-1859, 2009.

84. Stokes JB, Berns AS, Henrich WL, McKinney TD, Molitoris BA, Palmer BF, for the ASN committee on Corporate Relations. Managing conflicts of interest: The road ahead. J Am Soc Nephrol 20:1860-1862, 2009

85. Palmer BF. Prevention of intradialytic hypotension. Semin Dialysis Sep-Oct;22(5):489-91, 2009

86. Locatelli F, Palmer BF, Kashihara N, Ecder T. Renal protective effect of RAAS

17

blockade across the renal continuum, with a review of the efficacy and safety of valsartan. Curr Med Res Opin 25(12):2933-49, 2009

87. Zappe D, Palmer BF, Calhoun DA, Purkayastha D, Samuel R, Jamerson KA. Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension. J Human Htn 2010;24(7):483-91

88. Palmer BF. Physiology and pathophysiology with ascent to altitude. Am J Medical Sci. 2010;340(1):69-77

89. Palmer BF. A physiologic based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Ds. 2010;56(2):387-393

90. Glassock R, Bargman J, Palmer BF, Samaniego-Picota M, Fervenza F. Nephrology quiz and questionnaire. Clin J Am Soc Nephrol 2010; 5:1141-1160.

91. Palmer BF, Fenves A. Optimizing blood pressure control in patients with chronic kidney disease. Proc (Bayl Univ Med Cent). 2010;23:239-45

92. Palmer BF. Diagnostic approach and management of inpatient hyponatremia. J Hospital Med. 5: S1-S5, 2010

93. Palmer BF. New Horizons in the pharmacologic approach to hyponatremia: The V2 receptor antagonists. J Hospital Med. 5: S27-S32, 2010

94. Palmer BF. Management of sexual dysfunction: A commentary. Dialysis and Transplantation. September 2010 39:370-372.

95. White W, Bresalier R, Kaplan A, Palmer BF, Riddell R, Lesogor A, Chang W, Keefe D. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12000 patients with hypertension. J Clin Hypertension 12;765-75, 2010

96. Palmer BF. A Physiologic-Based Approach to the Evaluation of a Patient With Hypokalemia. Am J Kidney Ds. 2010; 56:1184-1190.

97. Palmer BF. Screening Tests for Renal Impairment in Patients with Type 2 Diabetes: The What, When, and How. Post Graduate Medicine. 123:7-14, 2011

98. Glassock R, Bleyer A, Hricik D, Palmer BF. Nephrology quiz and questionnaire: Part 1. Clin J Am Soc Nephrol 6:2318-2327, 2011.

99. White W, Bresalier R, Kaplan A, Palmer BF, Riddell R, Lesogor A, Chang W, Keefe D. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12942 patients. J Clin Hypertension 13:506-516, 2011

100. Palmer BF. Why are some dialysis patients chronically hypotensive in the absence of heart disease and volume depletion? Seminars in Dialysis 24:404-405, 2011

101. Palmer BF. Metabolic Complications Associated with Use of Diuretics. Seminars in Nephrology 31:542-552, 2011

102. Palmer BF, Glassock R, Bleyer A. Nephrology quiz and questionnaire: electrolytes. Clin J Am Soc Nephrol 7:1047-52, 2012

103. Palmer BF. Editorial: Hyperkalemia in pre-dialysis patients. Clin J Am Soc Nephrol. 7:1201-1202, 2012.

104. Palmer BF. Respiratory alkalosis. Am J Kidney Ds. 60:834-838, 2012. 105. Palmer BF, Glassock R, Bleyer A. American society of Nephrology quiz and

questionnaire 2012: electrolytes. Clin J Am Soc Nephrol 8:1048-1053, 2013. 106. Palmer BF. The role of V2 Receptor Antagonists in the Treatment of Hyponatremia.

Electrolyte Blood Pressure 11:1-8, 2013 107. Clegg DJ, Palmer BF. Correspondence: effects of an estrogen receptor α variant. N

Engl J Med 369:1663-1664, 2013.

18

108. Palmer BF, Clegg DJ. Ascent to altitude as a weight loss method: The good and bad of hypoxia inducible factor activation. Obesity 22: 311–317, 2014

109. Palmer BF. American society of Nephrology quiz and questionnaire 2013: Electrolytes and acid-base. Clin J Am Soc Nephrol 9: 1132–1137, 2014

110. McCullough PA, Beaver TM, Bennett-Guerrero E, Emmett M, Fonarow GC, Goyal A, Herzog CA, Kosiborod M, Palmer BF. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management. Rev Cardiovasc Med. 2014;15(1):11-23.

111. Kim M, Neinast MD, Frank AP, Sun K, Park J, Zehr JA, Vishvanath L, Morselli E, Amelotte M, Palmer BF, Gupta RK, Scherer PE, Clegg DJ. ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue. Mol Metab. 3(6):642-51. 2014

112. Morselli E, Fuente-Martin E, Finan B, Kim M, Frank A, Garcia-Caceres C, Navas CR, Gordillo R, Neinast M, Kalainayakan SP, Li DL, Gao Y, Yi CX, Hahner L, Palmer BF, Tschöp MH, Clegg DJ. Hypothalamic PGC-1α Protects Against High-Fat Diet Exposure by Regulating ERα. Cell Rep. 2014 Oct 23;9(2):633-45.

113. Palmer BF, Clegg DJ. Oxygen Sensing and Metabolic Homeostasis. Mol Cell Endocrinol. 397(1-2):51-58, 2014

114. Palmer BF. Arginine vasopressin anatagonists: an overview. Current Hypertension Reports 2015; 17: 510.

115. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015;402:113-9.

116. Neinast M, Frank A, Zechner J, Li Q, Vishvanath L, Palmer BF, Aguirre V, Gupta R, Clegg DJ. Activation of natriuretic peptides and the sympathetic nervous system following Roux-en-Y gastric bypass is associated with gonadal adipose tissues browning. Molec Metab 2015;4: 427-436.

117. Palmer BF. Renal Physiology: Regulation of Potassium Homeostasis. Clin J Am Soc Nephrol 2015;10:1050-60

118. Mayor R, Finch K, Zehr J, Morselli E, Neinast M, Frank A, Hahner L, Wang J, Rakheja D, Palmer BF, Rosenfeld C, Savani R, Clegg D. Maternal high fat diet is associated with impaired fetal lung development. Am J Physiol-Lung Cell Molec Physiol 2015;309:L360-8.

119. Palmer BF, Clegg DJ. Electrolyte and acid-base disorders in patients with diabetes mellitus. N Engl J Med 2015;373:548-59

120. Palmer BF, Clegg DJ. An Emerging Role of Natriuretic Peptides: Igniting the Fat Furnace to Fuel and Warm the Heart. Mayo Clin Proc 2015; 90: 1666–1678

121. Palmer BF, Clegg DJ. Diagnostic test interpretation: Hyperkalemia. J Am Med Assoc. 2015; 314: 2405-2406

122. Palmer BF, Clegg DJ. Letter and Reply for Electrolyte and Acid–Base Disturbances in Diabetes Mellitus. N Engl J Med 2015; 373: 2481-2483

123. Morselli E, Frank A, Palmer BF, Rodriguez-Navas C, Criollo A, Clegg D. A sexually dimorphic hypothalamic response to chronic high fat diet. International Journal of Obesity 2016; 40: 206–209.

124. Palmer BF, Rock A, Woodward E. Dose Comparison of Conivaptan (Vaprisol) in Patients with Euvolemic or Hypervolemic Hyponatremia - Efficacy, Safety, and Pharmacokinetics. Drug Design, Development and Therapy 2016 ;10:339-51.

125. Palmer BF, Clegg DJ. Achieving the benefits of a high potassium, Paleolithic diet, without the toxicity. Mayo Clin Proc 2016;91:496-508

19

126. Grodzinsky A, Goyal A, Gosch K, McCullough PA, Fonarow GC, Mebazaa A, Masoudi FA, Spertus JA, Palmer BF, Kosiborod M. Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction. Am J Med. 2016 Apr 6 (epub before press)

127. Palmer BF, Clegg DJ, Taylor SI, Weir MR. Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney. J Diabetes Complications. 2016 May 10. [Epub ahead of print]

128. Palmer BF. Potassium homeostasis in chronic kidney disease. Nephrol News Issues. 2016 Apr;30(4):suppl 8-10, 12-3.

Reviews, Chapters, Monographs and Editorials

1. Palmer BF, Toto RD, Alpern RJ. Sodium and potassium disturbance in the renal

patient. In: D. Levine, (ed.), Care of the Renal Patient, 2nd Ed. New York: W.B. Saunders Co., 1991, pp. 35-52.

2. Palmer BF, Henrich WL. Atheroembolic renal disease. In: R. Glassock, (ed)., Current Therapy in Nephrology and Hypertension, 3rd Ed. St. Louis: Mosby-Year Book, Inc., 1992. pp. 291-296.

3. Palmer BF, Henrich WL. The effect of dialysis on LV contractility. In: PS Alfrey, JD Harnett, (eds.), Cardiac Dysfunction in Chronic Uremia. Boston: Kluwer Academic Publishers, 1992, pp. 171-185.

4. Palmer BF, Alpern RJ, Seldin DW. The pathophysiology of edema. In: DW Seldin, G Giebisch, (eds.), The Kidney: Physiology and Pathophysiology, 2nd Ed. New York: Raven Press, 1992, pp. 2099-2141.

5. Dawidson I, Palmer B, Lu C, Risser R, Rooth P, Sagalowsky A, Sandor Z. Calcium antagonists improve the outcome after renal transplantation. In: T Godfraind et al., (eds.) Calcium Antagonists: Pharmacology and Clinical Research. Netherlands: Kluwer Academic Publishers, 1993, pp.355-361.

6. Palmer BF, Alpern RJ. The integrated renal response to disorders of tonicity. In: DW Seldin, G Giebisch, (eds.), Clinical Disturbances of Water Balance. New York: Raven Press, 1993, pp. 273-295.

7. Palmer BF. Chronic renal failure. In: RE Rakel, (ed.), Conn's Current Therapy. Philadelphia: W.B. Saunders, 1994, 671-677.

8. Palmer BF. Dialysate composition in hemodialysis and peritoneal dialysis. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. Baltimore: Williams and Wilkins, 1994, 8-21.

9. Palmer BF, Levi M. Effect of aging on renal function and disease. In: BM Brenner, FC rector, (Eds.), The Kidney. Fifth edition. WB Saunders, 1996, 2274-2296.

10. Palmer BF, Levi M. Kidney disease in the elderly. In: R Schrier, D Jahnigen, (eds.), Geriatric Medicine 3rd edition. Philadelphia: WB Saunders, 1996, 688-706.

11. Palmer BF, Henrich WL. Nephrotoxicity of non-steroidal antiinflammatory agents, analgesics, and angiotensin converting enzyme inhibitors. In: R Schrier (ed), Diseases of the Kidney, Sixth edition, W B Saunders, 1997, 1167-1188.

12. Palmer BF, Levi M. Renal function and disease in the aging kidney. In: R Schrier (ed), Diseases of the Kidney, Sixth edition, W B Saunders, 1997, 2293-2317.

20

13. Palmer BF, Toto RD, Alpern RJ. Sodium and potassium disorders in the renal patient. In: Levine DZ, (Ed.), Care of the Renal Patient. 3rd edition. WB Saunders, 1997, 32-49.

14. Palmer BF. Potassium disturbances associated with the use of diuretics. In: DW Seldin, G Giebisch, (eds.), Diuretic Agents: Clinical Physiology and Pathophysiology. Academic Press, 1997, 571-583.

15. Palmer BF. Acid-base disturbances associated with the use of diuretics. In: DW Seldin, G Giebisch, (eds.), Diuretic Agents: Clinical Physiology and Pathophysiology. Academic Press, 1997, 585-594.

16. Palmer BF. Extrarenal effects of diuretics. In: DW Seldin, G Giebisch, (eds.), Diuretic Agents: Clinical Physiology and Pathophysiology. Academic Press, 1997, 171-185.

17. Palmer BF. Diuretics in the treatment of metabolic alkalosis. In: DW Seldin, G Giebisch, (eds.), Diuretic Agents: Clinical Physiology and Pathophysiology. Academic Press, 1997, 483-494.

18. Palmer BF. Dialysate composition in hemodialysis and peritoneal dialysis. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. 2nd Edition, Baltimore: Williams and Wilkins, 1999, 22-40.

19. Palmer BF, Henrich WL. Autonomic neuropathy and hemodialysis stability in end-stage renal disease patients. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. 2nd Edition, Baltimore: Williams and Wilkins, 1999, 259-271.

20. Palmer BF, Henrich WL. Growth hormone metabolism in chronic renal failure. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

21. Palmer BF, Henrich WL. Cortisol metabolism in chronic renal failure. In: BD Rose, (ed), UpToDate. 1993-2015. ( A computer program that is updated three times per year)

22. Palmer BF, Henrich WL. Thyroid function in chronic renal failure. In: BD Rose, (ed) UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

23. Palmer BF, Henrich WL. Catecholamine metabolism in chronic renal failure. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

24. Palmer BF, Henrich WL. Carbohydrate and insulin metabolism in chronic renal failure. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

25. Palmer BF, Henrich WL. Uremic polyneuropathy. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

26. Palmer BF, Henrich WL. Uremic mononeuropathy. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

27. Palmer BF, Henrich WL, Snyder PJ. Sexual dysfunction in uremic women. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

28. Palmer BF, Henrich WL, Snyder PJ. Sexual dysfunction in uremic men. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

29. Burns MJ, Palmer BF. Valproic acid intoxication. In: BD Rose, (ed), UpToDate. 1993-2015 (yrs). ( A computer program that is updated three times per year)

30. Palmer BF. Dialysate composition in hemodialysis and peritoneal dialysis. In: Schrier RW, (ed.), Atlas of Diseases of the Kidney. Philadelphia: Current Medicine, 1999, 2.1-2.8.

31. Palmer BF. The dialysis prescription and urea modeling. In: Schrier RW, (ed.), Atlas of

21

Diseases of the Kidney. Philadelphia: Current Medicine, 1999, 6.1-6.8. 32. Palmer BF, Alpern RJ. Normal acid-base and acidotic states. In: Johnson RJ and

Feehally J (eds.) Principles of Nephrology. London: Mosby Intl, 2000, 12.1-12.14. 33. Choudhury D, Raj DSC, Palmer BF, Levi M. Effect of aging on renal function and

disease. In: BM Brenner (Ed.), The Kidney. 6th edition. WB Saunders, 2000, 2187-2215.

34. Palmer BF. Electrolyte disturbances in dialysis. In: DW Seldin, G Giebisch, (eds.), The Kidney: Physiology and Pathophysiology, 3rd Ed. Philadelphia: Lippincott Williams and Wilkins, 2000, 2789-2810.

35. Choudhury D, Palmer BF, Levi M. Renal function and dysfunction in aging In: DW Seldin, G Giebisch, (eds.), The Kidney: Physiology and Pathophysiology, 3rd Ed. Philadelphia: Lippincott Williams and Wilkins, 2000, 2572-2595.

36. Palmer BF, Alpern RJ, Seldin DW. Physiology and pathophysiology of sodium retention In: DW Seldin, G Giebisch, (eds.), The Kidney: Physiology and Pathophysiology, 3rd Ed. Philadelphia: Lippincott Williams and Wilkins, 2000, 1473-1517.

37. Palmer BF. Dialyzers, dialysates, and delivery devices. In: RJ Glassock, SG Massry, (eds.), Textbook of Nephrology, 4th Ed. Baltimore: Williams and Wilkins, 2001, 1488-1494.

38. Palmer BF, Alpern RJ. Renal handling of hydrogen and bicarbonate. In: RJ Glassock, SG Massry, (eds.), Textbook of Nephrology, 4th Ed. Baltimore: Williams and Wilkins, 2001, 391-396.

39. Palmer BF, Henrich WL. Nephrotoxicity of non-steroidal antiinflammatory agents, analgesics, and angiotensin converting enzyme inhibitors. In: R Schrier (ed), Diseases of the Kidney, 7th edition, W B Saunders, 2001, 1189-1209.

40. Porter GA, Palmer BF, Henrich WL. Clinical relevance. In: Marc E. De Broe, GA Porter, Bennett WM, Verpooten GA. (Eds) Clinical Nephrotoxicity: Renal Injury from Drugs and Chemicals, 2nd Edition . Kluwer Academic Pub. Dordrecht, 2003, 3-21.

41. Palmer BF, Alpern RJ. Normal acid-base balance and metabolic acidosis. In: Johnson RJ and Feehally J (eds.) Comprehensive Clinical Nephrology 2nd edition. London: Mosby Intl, 2003, 141-155.

42. Palmer BF. Dialysate composition in hemodialysis and peritoneal dialysis. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. 3rd Edition, Philadelphia: Williams and Wilkins, 28-44, 2003.

43. Palmer BF, Henrich WL. Autonomic neuropathy and hemodynamic stability in end-stage renal disease patients. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. 3rd Edition, Philadelphia: Williams and Wilkins, 282-295, 2003.

44. Palmer BF, Henrich WL. Toxic nephropathy. In: BM Brenner (Ed.), The Kidney. 7th edition. Philadelphia, Saunders, 2004, 1625-1658.

45. Palmer BF. Sexual Dysfunction in the Dialysis Patient. In J Winchester, W Horl, K Koch, R Lindsay, C Ronco (eds), Replacement of Renal function by Dialysis, 6th edition, Kluwer Academic Publishers, 1333-1342, 2004

46. Palmer BF, Yee J, Narins RG. Metabolic acidosis and metabolic alkalosis. In: Oxford Textbook of Clinical Nephrology. 3rd Edition, 321-343, 2005.

47. Palmer BF, Henrich WL. Analgesics and the Kidney. In: A Greenberg (ed), Primer on Kidney Diseases. 4th edition, Philadelphia, Elsevier Science, 324-330, 2005

48. Palmer BF. Hyponatremia. In: RE Rakel, (ed.), Conn's Current Therapy. Philadelphia: W.B. Saunders, 720-723, 2006

22

49. Palmer BF. Kidney disease genes and hypertension. In: E Mohler and R Townsend, (eds.), Advanced Therapy in Hypertension and Vascular Disease. Ontario, BC Decker Inc, 652-659, 2006

50. Palmer BF, Rose BD. Cerebral salt wasting. In: BD Rose, (ed), UpToDate. 2006-2015. (A computer program that is updated three times per year)

51. Lai KN, Kisielius P, Palmer BF. Genitourinary tract and male reproductive organs. In: J Daugirdas, P Blake, and T Ing (eds.), Handbook of Dialysis 4th ed. Philadelphia, Lippincott Williams and Wilkes. 2007, 656-671

52. Palmer BF. Hyponatremia. In: RE Rakel and E Bope (eds.), Conn's Current Therapy. Philadelphia: Saunders Elsevier, 2007, 693-696

53. Palmer BF, Henrich WL. Nephrotoxicity of non-steroidal antiinflammatory agents, analgesics, and angiotensin converting enzyme inhibitors. In: R Schrier (ed), Diseases of the Kidney, 8th edition, Lippincott Williams and Wilkins, 2007, 1082-1098.

54. Palmer BF, Alpern RJ. Normal Acid-Base Balance. In: Johnson RJ, Feehally J, Floege J (eds.) Comprehensive Clinical Nephrology 3rd edition. Philadelphia: Elsevier Inc. 2007, 141-146.

55. Palmer BF, Alpern RJ. Metabolic acidosis. In: Johnson RJ, Feehally J, Floege J (eds.) Comprehensive Clinical Nephrology 3rd edition. Philadelphia: Elsevier Inc. 2007, 147-157.

56. Palmer BF. Metabolic abnormalities: Evaluation of sexual dysfunction. In: Nissenson A, Fine R. (Eds), Dialysis Therapy. 4th edition. Philadelphia: Elsevier Inc. 2007, 930-939.

57. Palmer BF. Henrich WL. Electrolyte disturbances in dialysis. In: Alpern RJ and Hebert SC (eds.), The Kidney: Physiology and Pathophysiology, 4th Ed. San Diego Elsevier, 2008, 2719-2736

58. Palmer BF, Alpern RJ, Seldin DW. Physiology and pathophysiology of sodium retention and wastage. In: Alpern RJ and Hebert SC (eds.), The Kidney: Physiology and Pathophysiology, 4th Ed. San Diego Elsevier, 2008, 1005-1049

59. Singh AK, Mulder J, Palmer BF. Endocrine aspects of kidney disease. In: BM Brenner (Ed.), The Kidney. 8th edition. Philadelphia, Saunders, 2008, 1744-1756

60. Palmer BF. Treatment of metabolic and respiratory alkalosis. In: Christopher Wilcox (ed) Tomas Berl (section editor) Therapy in nephrology and hypertension. 3rd Edition. Saunders Elsevier, Philadelphia, 2008, 381-387

61. Palmer BF. Sexual Dysfunction in Men and Women with Chronic Kidney Disease. In: Ajay K Singh and Gordon H. Williams (eds). Textbook of NephroEndocrinology. Elsevier 2009, 429-440

62. Lin Fang-Ying, Palmer BF, Henrich WL. Analgesic nephropathy. In: A Greenberg (ed), Primer on Kidney Diseases. 5th edition, Philadelphia, Elsevier Science, 2009, 314-321

63. Palmer BF. Dialysate composition in hemodialysis and peritoneal dialysis. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. 4th Edition, Philadelphia: Lippincott Williams and Wilkins, 2009, 25-41.

64. Palmer BF, Henrich WL. Hemodynamic stability and autonomic neuropathy in end-stage renal disease patients. In: WL Henrich, (ed.), The Principles And Practice of Dialysis. 4th Edition, Philadelphia: Lippincott Williams and Wilkins, 2009, 357-369.

65. Palmer BF. Fluid and electrolytes. Medical Knowledge Self Assessment Program, MKSAP 15. 2009; 8-19.

66. Palmer BF. Acid-Base Disorders. Medical Knowledge Self Assessment Program, MKSAP 15. 2009; 19-30

23

67. Palmer BF, DuBose TD. Disorders of potassium. In Schrier RW (ed.) Renal and Electrolyte Disorders 7th edition. Philadelphia: Lippincott Williams & Wilkins 2010, 137-165.

68. Palmer BF, Alpern RJ. Normal Acid-Base Balance. In: Floege J, Johnson RJ, Feehally J (eds.) Comprehensive Clinical Nephrology 4th edition. St Louis: Elsevier Saunders. 2010, 149-154.

69. Palmer BF, Alpern RJ. Metabolic acidosis. In: Floege J, Johnson RJ, Feehally J (eds.) Comprehensive Clinical Nephrology 4th edition. St Louis: Elsevier Saunders. 2010, 155-166.

70. Palmer BF. Respiratory Acid-Base Disorders. In Eds: Lerma EV, Nissenson A, (eds) Nephrology Secrets 3rd edition. Philadelphia: Elsevier. 2012, 605-611.

71. Palmer BF. Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient. In: GL Bakris (ed). The kidney in heart failure. New York, Springer 2012, 51-65.

72. Palmer BF. Respiratory Acid-Base Disorders. In: D Mount, M Sayegh, Ajay Singh (eds) Core Concepts in the Disorders of Fluid, Electrolytes and Acid-Base Balance New York, Springer 2013, 297-306.

73. Palmer BF. Nephrotoxicity of non-steroidal antiinflammatory agents, analgesics, and inhibitors of the renin-angiotensin system. In: T Coffman, B Molitoris, R Falk, E Neilson, R Schrier (eds), Schrier’s Diseases of the Kidney, 9th edition, Lippincott Williams and Wilkins, 943-958, 2013.

74. Palmer BF. Alpern RJ, Seldin DW. Pathophysiology of Sodium Retention and Wastage. In: Alpern RJ, Caplan M, Moe O (eds.), Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology, 5th Ed. San Diego Elsevier, 1283-1317, 2013.

75. Palmer BF. Individualizing the Dialysate to Address Electrolyte Disturbances in the Dialysis Patient. In: Alpern RJ, Caplan M, Moe O (eds.), Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology, 5th Ed. San Diego Elsevier, 3125-3150, 2013.

76. Palmer BF, Emmett M. Renal complications following ureteral diversion. In: BD Rose, (ed), UpToDate. 2014-2015. (A computer program that is updated three times per year).

77. Emmett M, Palmer BF. Acid-base and electrolyte abnormalities with diarrhea. In: BD Rose, (ed), UpToDate. 2014-2015. (A computer program that is updated three times per year).

78. Palmer BF. Normal Acid-Base Balance. In: Johnson RJ, Feehally J, Floege J, (eds.) Comprehensive Clinical Nephrology 5th edition. Philadelphia: Elsevier Saunders. 142-148, 2015.

79. Palmer BF. Metabolic acidosis. In: Johnson RJ, Feehally J, Floege J (eds.) Comprehensive Clinical Nephrology 5th edition. Philadelphia: Elsevier Saunders. 149-159, 2015.

80. Palmer BF. Potassium metabolism in chronic kidney disease. In: Kimmel P, Rosenberg M (eds.) Chronic renal disease. Elsevier. 381-390, 2015.

81. Palmer BF. Fluid and electrolytes. Andreoli & Carpenter’s Cecil Essentials of Medicine, 9th Ed. Benjamin I, Griggs R, Wing E, Fitz J (eds.). Philadelphia Elsevier, 299-313, 2016.

82. Palmer BF. Metabolic abnormalities: Evaluation of sexual dysfunction. In: Nissenson A, Fine R. (Eds), Dialysis Therapy. 5th edition. Philadelphia: Elsevier Inc. (In press)

83. Palmer BF. Dialysate composition. In: Nissenson A, Fine R. (Eds), Dialysis Therapy. 5th edition. Philadelphia: Elsevier (In Press)

84. Van Buren PN, Palmer BF. Dialysate composition in hemodialysis and peritoneal

24

dialysis. In: Weir M, Lerma E, (eds.), Henrich’s Principles And Practice of Dialysis. 5th Edition, Philadelphia: Lippincott Williams and Wilkins, (In Press)

85. Palmer BF, Henrich WL. Hemodynamic stability and autonomic neuropathy in end-stage renal disease patients. In: Weir M, Lerma E, (eds.), Henrich’s Principles And Practice of Dialysis. 5th Edition, Philadelphia: Lippincott Williams and Wilkins, (In Press)

86. Palmer BF. Sexual Dysfunction in Men and Women with Chronic Kidney Disease. In: Ajay K Singh and Gordon H. Williams (eds). Textbook of NephroEndocrinology 2nd edition. Elsevier 2016, (In Press)

87. Palmer BF, DuBose TD. Disorders of potassium. In Schrier RW (ed.) Renal and Electrolyte Disorders 8th edition. Philadelphia: Lippincott Williams & Wilkins 2016, (In Press)

88. Emmett M, Palmer BF. Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis. In: BD Rose, (ed), UpToDate. 2016. (A computer program that is updated three times per year).

Abstracts 1. Palmer BF, Grillo FG, Putrescine transport in renal microvillus vesicles. The FASEB J. 2:6938,

1988. 2. Grillo FG, Palmer BF. Stretch activated putrescine transport in rabbit renal microvillus vesicles.

The FASEB J. 2:2651, 1988. 3. Palmer BF, Toto RD, Cyclosporine-A induced severe neurologic toxicity in three renal transplant

patients. Eleventh Intl. Congress of Nephrology, Tokyo, Japan, July 1990. 519 A, July 1990. 4. Palmer BF, Dawidson I, Sagalowsky A, Lu CY. Calcium channel blockers improve the outcome

of cadaver renal transplantation. J. Am. Soc. Nephrol. 1:767, 1990. 5. Dawidson I, Lu C, Palmer B, Peters P, Risser R, Sagalowsky A, Sandor Z, Seney F. Verapamil

Improves the outcome after cadaver renal transplantation. Tenth Annual Am. Soc. Transplant Physicians, 64A, 1991.

6. Palmer BF, Dawidson I, Sagalowsky A, Sandor Z, Lu C. Delayed function independently exerts an adverse effect on outcome of cadaveric renal transplant. J. Am. Soc. Nephrol. 2:811, 1991.

7. Palmer B, Lu C, Dawidson I, Sagalowsky A. Chronic use of calcium channel blockers improves renal transplant results. J Urology 145:346a, 1991.

8. Orsulak PJ, Lu CY, Dawidson I, Palmer B, Sagalowsky A. Evaluation of the Abbott TDx monoclonal flourescence polarization immunoassay for cyclosporine A. J Urology 147:328a, 1992.

9. Dawidson I, Melone D, Lu C, Palmer B, Sagalowsky I. Early experience with OG 37-325 in cadaver renal transplantation. J Urology. 149:306a, 1993.

10. O'Byrne D, Islam K, Palmer B, Devaraj S, Jialal I. The effect of vitamin E supplementation on LDL oxidation in dialysis patients. Experimental Biology. 1998.

Curriculum vitaelisbonclinicalnephrologyupdate.com/images/speakers/Biff-Franklin... · 1 Curriculum...

Documents

Transcript of Curriculum vitaelisbonclinicalnephrologyupdate.com/images/speakers/Biff-Franklin... · 1 Curriculum...